科普專欄–薯不揀單 - 深入淺出–以免疫治療(Immunotherapy)手段醫治癌細胞(二)

上集講述了PD1/PDL1在醫治癌細胞免疫治療方面的重要性，接下來我們將會繼續深入探討問題。1355Please respect copyright.ＰＥＮＡＮＡDQphRiyuwB
1355Please respect copyright.ＰＥＮＡＮＡiXAsc43ltw
上集：https://www.penana.com/article/4711251355Please respect copyright.ＰＥＮＡＮＡnwRCAZgMuC
1355Please respect copyright.ＰＥＮＡＮＡ77a7Va6UVB
1355Please respect copyright.ＰＥＮＡＮＡfmpNJSrAaa
1355Please respect copyright.ＰＥＮＡＮＡM5tRZSqUIU
（圖1）雖然阻擋PD1/PDL1可以增強T cell辨認癌細胞的能力，但另一個重要的問題是，如何確保有足夠的T cell殺滅癌細胞呢?1355Please respect copyright.ＰＥＮＡＮＡk4wLQHZJBl
1355Please respect copyright.ＰＥＮＡＮＡQAdoUgLKcs
就算成功糾正免疫系統細胞懂得把癌細胞辨認為外來之物，但免疫系統細胞數量不足的話，依然是不會達到重大效果的。1355Please respect copyright.ＰＥＮＡＮＡhBmujGJq09
1355Please respect copyright.ＰＥＮＡＮＡ5sBf0cUCA6
換句話說，我們需要一道能夠提升針對癌細胞的T cell數量手段。1355Please respect copyright.ＰＥＮＡＮＡKuecCRjJLd
1355Please respect copyright.ＰＥＮＡＮＡVIdNWfEfVc
1355Please respect copyright.ＰＥＮＡＮＡmQ0uwoKe8o
1355Please respect copyright.ＰＥＮＡＮＡLeStu7r4Gm
（圖2）T cell的產生數量，接近可以說是由Antigen Presenting Cells(APC)來決定;1355Please respect copyright.ＰＥＮＡＮＡX9vbtw1h6v
APC可以睇成為一堆負責把癌細胞獨特Neoantigen帶來T cell面前的細胞。1355Please respect copyright.ＰＥＮＡＮＡrYMXptVhLr
1355Please respect copyright.ＰＥＮＡＮＡySFcgLusUb
忘記甚麼是Neoantigen的話，可重溫上一集。1355Please respect copyright.ＰＥＮＡＮＡimVUe7kgkX
1355Please respect copyright.ＰＥＮＡＮＡJIAe2up6xb
當APC展示癌細胞的Neoantigen予T cell的receptor後，另一個必需的動作就是T cell表面的CD28與APC表面的B7合併。1355Please respect copyright.ＰＥＮＡＮＡcK9aYlMC1V
1355Please respect copyright.ＰＥＮＡＮＡuRZb4BAEzE
只要兩者條件達成的話，負責對付對應癌細胞的T cell數量及效力便會大增。1355Please respect copyright.ＰＥＮＡＮＡWzcdkzfAbD
1355Please respect copyright.ＰＥＮＡＮＡSaf4mX6N57
1355Please respect copyright.ＰＥＮＡＮＡshGvLInA8h
1355Please respect copyright.ＰＥＮＡＮＡao55SYNH2T
（圖3）然而，當T cell數量產生至一定程度的時候，T cell便會產生出CTLA4。CTLA4會搶奪CD28的位置，與B7合併。1355Please respect copyright.ＰＥＮＡＮＡngZujE6aKi
1355Please respect copyright.ＰＥＮＡＮＡ61fOZhApNK
而當CTLA4與B7合併後，T cell所產生的數量及威力就會大減。1355Please respect copyright.ＰＥＮＡＮＡjphAHb4nfM
1355Please respect copyright.ＰＥＮＡＮＡMfjWH5RYvY
這個CTLA4產生的機制是與生俱來的，目的就是為了避免產生過量的T cell，以免身體會產生不良反應。1355Please respect copyright.ＰＥＮＡＮＡVRTT9EVupM
1355Please respect copyright.ＰＥＮＡＮＡXdbL27wQng
1355Please respect copyright.ＰＥＮＡＮＡVir6WOU6TK
（圖4）只不過的是，現時癌細胞大敵當前，燃眉之急就是要調動大量的T cell前往討伐癌細胞。1355Please respect copyright.ＰＥＮＡＮＡ9LX171aOeS
1355Please respect copyright.ＰＥＮＡＮＡxKjq3mYtR9
為此，我們重施應對PD1/PDL1故技，利用抗體阻擋CTLA4，確保CD28及B7持續合併，不斷產生效力高強的T cell。1355Please respect copyright.ＰＥＮＡＮＡcalxW4WdZ7
1355Please respect copyright.ＰＥＮＡＮＡf0u8ujhI6U
1355Please respect copyright.ＰＥＮＡＮＡFgmTdlP2us
（圖5）簡略的總結來說，為了確保有足夠的T cell消滅癌細胞，我們不惜採用阻擋CTLA4的抗體，號令身體持續產生效力高強的T cell。1355Please respect copyright.ＰＥＮＡＮＡNdrhohhlO1
而另一邊廂，我們亦同時利用阻擋PD1/PDL1的抗體，確保T cell能夠順利把癌細胞辨認成為外來物，將其制裁。1355Please respect copyright.ＰＥＮＡＮＡSzZz3FGjxn
1355Please respect copyright.ＰＥＮＡＮＡkYTKfnvUJw
這CTLA4抗體及PD1/PDL1抗體的雙管齊下療法，將能大大提升免疫治療的效率。1355Please respect copyright.ＰＥＮＡＮＡXz11Ano1zG
1355Please respect copyright.ＰＥＮＡＮＡSkOBoyK19U
但是，並不是所有病人也能依靠這方法而得益，原因是T cell沒法能夠順利抵達癌細胞的位置以及滲入癌細胞的內部作有效的消滅。1355Please respect copyright.ＰＥＮＡＮＡadBhmEU8LD
1355Please respect copyright.ＰＥＮＡＮＡePTUW5nrjz
這一方面，我們將會在下一篇免疫治療的最終章再作探討。1355Please respect copyright.ＰＥＮＡＮＡUZYmLA9bFM
1355Please respect copyright.ＰＥＮＡＮＡFFN3MoIzgH
1355Please respect copyright.ＰＥＮＡＮＡtsfXbTKA0z
如果想我快啲出文的話，請入去Penana網站科普專欄–薯不揀單俾一個like以及Bookmark，這對我非常之重要。1355Please respect copyright.ＰＥＮＡＮＡ79hfwBNIGg
1355Please respect copyright.ＰＥＮＡＮＡw3LeP1j1uN
Link: https://www.penana.com/story/66244/%E7%A7%91%E6%99%AE%E5%B0%88%E6%AC%84-%E8%96%AF%E4%B8%8D%E6%8F%80%E5%96%AE/toc1355Please respect copyright.ＰＥＮＡＮＡD3hYSLaiaz
1355Please respect copyright.ＰＥＮＡＮＡau3cP05AVb
同時亦可以在Penana網站裡按「買一嚿/半嚿薯仔」，以課金的方式推動我繼續搜羅資料寫文，多謝。1355Please respect copyright.ＰＥＮＡＮＡcpRnoezeUV
1355Please respect copyright.ＰＥＮＡＮＡtLy7g8dQci
Link:1355Please respect copyright.ＰＥＮＡＮＡl1GeWO2YVJ
https://www.penana.com/user/27349/%E8%96%AF%E4%BB%94%E8%81%9E%E8%8C%B1%E8%8E%89/portfolio1355Please respect copyright.ＰＥＮＡＮＡsZigCwWSFx
1355Please respect copyright.ＰＥＮＡＮＡhTczhvXoOm
1355Please respect copyright.ＰＥＮＡＮＡJVpPs1Z7eH
有興趣接收科普資訊的話，歡迎follow IG: potatopigtongue。1355Please respect copyright.ＰＥＮＡＮＡMbe2AAYAgE